Učitavanje...

Immune Checkpoint Inhibitor‐Associated Myocarditis

Immune checkpoint inhibitors (ICIs) are approved for a wide range of malignancies. They work by priming the immune system response to cancer and have changed the landscape of available cancer treatments. As anticipated, modulation of the regulatory controls in the immune system with ICIs results in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Ganatra, Sarju, Neilan, Tomas G.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6156176/
https://ncbi.nlm.nih.gov/pubmed/29802219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0130
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!